Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin.
CAT No: R1350
CAS No:137235-80-4
Synonyms/Alias:Fibrinogen-Binding Peptide;137235-80-4;Glu-his-ile-pro-ala;Glutamyl-histidyl-isoleucyl-prolyl-alanine;(4S)-4-amino-5-[[(2S)-1-[[(2S,3S)-1-[(2S)-2-[[(1S)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;DTXSID80160116;L-Alanine, N-(1-(N-(N-L-alpha-glutamyl-L-histidyl)-L-isoleucyl)-L-prolyl)-;CHEMBL1409520;DTXCID5082607;HY-P1741;NCGC00167251-01;DA-63437;MS-30246;CS-0095106;G12502;(S)-4-amino-5-((S)-1-((2S,3S)-1-((S)-2-((S)-1-carboxyethylcarbamoyl)pyrrolidin-1-yl)-3-methyl-1-oxopentan-2-ylamino)-3-(1H-imidazol-4-yl)-1-oxopropan-2-ylamino)-5-oxopentanoic acid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More